Eric Hedrick - Feb 25, 2022 Form 4 Insider Report for EQRx, Inc. (EQRX)

Role
Chief Physician Executive
Signature
/s/ William Collins, Attorney-in-Fact
Stock symbol
EQRX
Transactions as of
Feb 25, 2022
Transactions value $
$0
Form type
4
Date filed
3/1/2022, 04:31 PM
Previous filing
Dec 20, 2021
Next filing
Jan 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EQRX Stock Option (Right to Buy) Award $0 +505K $0.00 505K Feb 25, 2022 Common Stock 505K $3.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest and become exercisable in 48 equal monthly installments commencing February 1, 2022, subject to the Reporting Person's continuous service as of each vesting date.